Condition

Hepatitis C Virus Infection, Response to Therapy of

ClinicalTrials.gov condition label

Clinical trials5

Recruiting1

Common interventions6

Lead sponsors shown4

Clinical trials

5 shown

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional StructuresNCT05361603 · 2017-05-24

RECRUITING

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyNCT04768517 · 2021-02-09

UNKNOWN

Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency VirusNCT03369327 · 2017-01-01

COMPLETED

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsNCT03250910 · 2016-08-01

COMPLETED

CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeSNCT02402218 · 2015-08-01

COMPLETED

Common interventions

RibavirinDRUG1sofosbuvir and daclatasvirDRUG1Sofosbuvir and VelpatasvirDRUG1Usual CareOTHER1Usual care plus incentivesOTHER1Usual care plus peer-mentorsOTHER1

Leading sponsors

National Taiwan University Hospital2Johns Hopkins University1Tehran University of Medical Sciences1University Hospital, Limoges1

Trial status mix

COMPLETED3

RECRUITING1

UNKNOWN1

Phase mix

NA1

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.